Page 138 - 4PDF Alin Dexametasona flipbook

DEXAMETASONA COMO ANTIEMÉTICO EN QUIMIOTERAPIA

Referencias bibliográficas

1. Grunberg SM, Hesketh PJ. Control of Chemotherapy-Induced Eme-
sis. N Engl J Med 1993; 329:1790-1796
2. Chandrakantan A, Glass PSA. Multimodal therapies for postopera-
tive nausea and vomiting and pain. British Journal of Anaesthesia.
2011; 107:i27-i40.
3. León- Álvarez E. Neurofisiología de la náusea y vómito. Rev Mex
Anest 2013; 36 (2): S361-S362.
4. Kimmick GG, Fleming R, Muss HB, Balducci L. Cancer chemothe-
rapy in older adults. A tolerability perspective. Drugs Aging. 1997
Jan; 10(1):34-49.
5. Diaz-Rubio E, Martín M, (eds). Antiemeticteraphy; Current status
and future prospects. Creaciones Elba SA, Madrid, 1992; 57-68.
6. Tratamiento de la emesis inducida por quimioterapia. Anales Sis San
Navarra. 2004, vol.27, suppl.3, pp.117-123. ISSN 1137-6627.
7. Hesketh PJ. Comparative review of 5-HT3 receptor antagonists in
the treatment of acute Chemotherapy-Induced nausea and vomiting.
Cancer Invest 2000; 18: 163-173.
8. Ondansetron versus granisetron both combined with dexametha-
sone, in the prevention of cisplatin-induced emesis. Italian Group
of Antiemetic Research. Ann Oncol. 1995 Oct; 6(8):805-10.
9. Kubota K, Saito M, Aogi K, Sekine I, Yoshizawa H, Yanagita Y, Sakai
H, Inoue K, Kitagawa C, Ogura T. Control of nausea with palono-
setron versus granisetron, both combined with dexamethasone, in
patients receiving cisplatin- or anthracycline plus cyclophosphami-
de-based regimens. Support Care Cancer. 2016 Sep; 24(9):4025-33.
Doi: 10.1007/s00520-016-3203-5. Epub 2016 Apr 29.
10. Loannidis JP, Hesketh PJ, Lau J. Contribution of dexamethasone to
control of Chemotherapy-Induced nausea and vomiting: a meta-analysis
of randomized evidence. J Clin Oncol. 2000 Oct 1; 18(19):3409-22.

137